MYUNGMOON Pharm co.,Ltd

Symbol: 017180.KS

KSC

2030

KRW

Market price today

  • -10.9256

    P/E Ratio

  • -7.6492

    PEG Ratio

  • 68.06B

    MRK Cap

  • 0.00%

    DIV Yield

MYUNGMOON Pharm co.,Ltd (017180-KS) Financial Statements

On the chart you can see the default numbers in dynamics for MYUNGMOON Pharm co.,Ltd (017180.KS). Companys revenue shows the average of 121622.024 M which is 0.083 % gowth. The average gross profit for the whole period is 62137.754 M which is 0.148 %. The average gross profit ratio is 0.514 %. The net income growth for the company last year performance is -1.575 % which equals -2.489 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of MYUNGMOON Pharm co.,Ltd, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.026. In the realm of current assets, 017180.KS clocks in at 81436.186 in the reporting currency. A significant portion of these assets, precisely 11664.446, is held in cash and short-term investments. This segment shows a change of 0.168% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 6195.033, if any, in the reporting currency. This indicates a difference of -1025.304% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 12584.2 in the reporting currency. This figure signifies a year_over_year change of 0.088%. Shareholder value, as depicted by the total shareholder equity, is valued at 83453.011 in the reporting currency. The year over year change in this aspect is -0.068%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 38927.805, with an inventory valuation of 30280.25, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 267.49. Account payables and short-term debt are 16746.44 and 77437.8, respectively. The total debt is 90482.2, with a net debt of 82520.4. Other current liabilities amount to 20717.99, adding to the total liabilities of 147794.26. Lastly, the referred stock is valued at 0, if it exists.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

40812.3711664.49984.210516.6
13088
8485.7
9008.7
8823.6
22250.5
11532.6
12777.9
12013.7
10597.3
7600.6
12507.9
5346.3
8203.6
2569.4

balance-sheet.row.short-term-investments

15829.163702.75126.73703.9
8534.8
7913.6
8385.7
7426.4
4624.4
9034.5
8166.5
8922.8
7729
4411.3
9986
890
496.5
2251.5

balance-sheet.row.net-receivables

151220.2438927.835062.930917.9
37243.4
66177.3
77515.1
76812
70486.5
0
71638.4
0
0
86973.3
0
0
0
0

balance-sheet.row.inventory

125144.4930280.325659.826031.6
30245.9
26078.5
20447
20918
19117
18389.9
17498.3
16476.4
18106.5
15994.5
12952.8
11961.8
8786.2
6153.7

balance-sheet.row.other-current-assets

991.67563.700
0
0
0
0
0
67002.5
0
74048.5
71446.7
0
53147.7
47658.2
39824.8
29389.8

balance-sheet.row.total-current-assets

318168.7781436.270706.967466.1
80577.3
100741.6
106970.8
106553.6
111853.9
96925
101914.7
102538.6
100150.4
110568.4
78608.4
64966.3
56814.6
38112.9

balance-sheet.row.property-plant-equipment-net

563018.84140195.9141776.6142861.1
149944.4
154201.8
131418.1
125420.4
105795.8
98089.1
78001.1
77866.9
75303
75113.2
65398.3
63369.8
29498.4
13226.3

balance-sheet.row.goodwill

0000
434.4
434.4
434.4
434.4
434.4
444.4
5942.9
5932.9
5932.9
5792.9
5306.9
5637.7
130.8
23.1

balance-sheet.row.intangible-assets

828.65267.5318.5247.4
330
569.7
1379.8
1278.2
1336.1
2845.5
2798.6
4366.5
4470.4
5480.2
681.3
768.3
970.8
495.5

balance-sheet.row.goodwill-and-intangible-assets

1093.73267.5318.5247.4
764.4
1004.1
1814.2
1712.6
1770.6
3289.9
8741.4
10299.4
10403.3
11273.1
5988.3
6406
1101.7
518.6

balance-sheet.row.long-term-investments

7474.676195-669.5-458.9
-6379
-4204.6
-6477.5
-6524.8
-3544.2
-8435.6
-6586.8
-7613.5
-5559
455
-4110
9060.1
6119
3090.7

balance-sheet.row.tax-assets

32688.738108.88168.34273.1
4273.1
4154.2
477.2
7426.4
4624.4
9034.5
8166.5
8922.8
7729
4411.3
603.7
824.4
475.4
668.7

balance-sheet.row.other-non-current-assets

19081.89345.310149.18874.3
13844.7
8544.6
8863
488.8
574.9
514.3
423.7
396.1
310.3
682.8
17662
9223.4
3447.7
3752

balance-sheet.row.total-non-current-assets

623357.86155112.6159742.9155797
162447.7
163700.1
136095
128523.3
109221.5
102492.3
88745.9
89871.8
88186.7
91935.4
85542.4
88883.7
40642.2
21256.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

941526.63236548.8230449.8223263.1
243025
264441.7
243065.8
235076.9
221075.4
199417.3
190660.6
192410.4
188337.1
202503.8
164150.8
153850
97456.8
59369.3

balance-sheet.row.account-payables

68719.6916746.415676.913632.5
15905.2
16683.3
15481.3
14943.6
13364.9
10351.4
11056.9
8950.7
10196.4
12089.8
9066.9
7295.8
5811.8
5719.2

balance-sheet.row.short-term-debt

309820.9677437.875853.478174.5
91091.4
92863.9
91314.9
84111.8
83498.1
90956.2
85449.4
91092.9
67112.6
67548.9
41580.9
34320.4
5079.9
12043.8

balance-sheet.row.tax-payables

2495.4987.41240.2614.4
1042.1
4748.1
2368.5
2986.7
3590.3
6814.5
2124.3
2689.3
1378.3
2499
2179.3
1926
1882.1
2287.4

balance-sheet.row.long-term-debt-total

44617.8212584.27303.65956
7702.2
24813.5
9473.1
3093.1
186.2
620.3
1922.1
101.7
20350
21325.5
30140.4
33971.3
15631.6
7951.6

Deferred Revenue Non Current

2346.73921270.7782.7
465.2
520.2
612.6
0
0
0
6205.8
0
4512.1
3792.1
0
3741.2
3886.8
0

balance-sheet.row.deferred-tax-liabilities-non-current

14083.22---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

44331.512071818192.55565.7
4860.2
7299.2
14190.6
0
0
8984.3
0
0
0
0
0
5896.5
0
2976.3

balance-sheet.row.total-non-current-liabilities

113983.1531421.424360.924301.7
26930.2
50863.8
26646.6
18821.9
15889.2
15191.4
10350.4
7734.5
27833.7
28950.6
36223.4
40583.4
22278.9
10593.8

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

3946.66460.22256.72247.9
2385.1
1645.4
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

576068.71147794.3135182.4137389.4
152250.3
184246.2
150001.9
133358.1
126395.5
132297.8
117508.1
119212.9
115468.6
119372.1
97024.4
90022.1
41533.2
33620.5

balance-sheet.row.preferred-stock

11583.5000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

67906.9116976.716976.716976.7
16976.7
12270
12270
12020
11610
9055
8755
8500
8500
8165.8
5500
5293.6
5100
3830.4

balance-sheet.row.retained-earnings

29003.54372011425.2-39975.7
-33723.5
-10478.4
12934.5
20000.9
13656.2
8101.3
38803.2
38554
37388.4
50068.8
29554.2
27093
24829.6
19966.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

31571.5328793.728793.728793.7
29627.7
31705.2
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

203864.733962.632326.574462.2
74320.4
43012.8
64475.3
65687.4
65728.5
46040.2
21423.3
21434.7
21369.1
19414.5
26343.6
26186
25994
1952.2

balance-sheet.row.total-stockholders-equity

343930.198345389522.180256.9
87201.3
76509.6
89679.8
97708.3
90994.6
63196.5
68981.6
68488.7
67257.4
77649
61397.8
58572.6
55923.6
25748.8

balance-sheet.row.total-liabilities-and-stockholders-equity

941526.63236548.8230449.8223263.1
243025
264441.7
243065.8
235076.9
221075.4
199417.3
190660.6
192410.4
188337.1
202503.8
164150.8
153850
97456.8
59369.3

balance-sheet.row.minority-interest

21527.735301.55745.35616.8
3573.5
3685.9
3384.1
4010.6
3685.3
3923
4170.8
4708.8
5611.1
5482.7
5728.6
5255.3
0
0

balance-sheet.row.total-equity

365457.9288754.595267.585873.7
90774.8
80195.5
93063.9
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

941526.63---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

23303.839897.74457.23245.1
2155.8
3709
1908.2
901.5
1080.3
598.9
1579.6
1309.3
2170.1
4866.3
5876
9950.1
6615.5
5342.2

balance-sheet.row.total-debt

355169.890482.28315784130.4
98793.6
117677.4
100788
87204.9
83684.3
91576.5
87371.5
91194.6
87462.6
88874.3
71721.3
68291.6
20711.6
19995.3

balance-sheet.row.net-debt

330186.5982520.478299.477317.7
94240.3
117105.2
100165.1
85807.7
66058.3
89078.4
82760
88103.7
84594.4
85685
69199.3
63835.4
13004.5
19677.4

Cash Flow Statement

The financial landscape of MYUNGMOON Pharm co.,Ltd has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -3.317. The company recently extended its share capital by issuing 0, marking a difference of -0.000 compared to the previous year. The company's investing activities resulted in net cash usage, amounting to 1822651864.000 in the reporting currency. This is a shift of -1.370 from the previous year. In the same period, the company recorded 3562.69, 472.33, and -8199.36, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated 0 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 15329.19, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

-6328.96-4524.87976.1-6804.3
-27753
-20832.8
327.9
8131.2
6474.1
-17864.1
-43
201.3
-12746.4
4067.1
2331.2
2800.9
4863.3
6583.2

cash-flows.row.depreciation-and-amortization

3812.353562.74238.54203
4201.1
3661.2
1913.7
2021
2002.7
2022
2305.8
2255.2
2252.4
2278.5
3088.9
3423.6
2420.3
1326.1

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
2606.3
2843.4
2768.4
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
73.2
379.8
307
0

cash-flows.row.change-in-working-capital

-5937.83-6037.7-5513.35674.5
10855
-3361.6
6749
-1435.7
-2472.5
-4079.8
-4450.9
-4611.3
8736
-12822.9
-5374
-13672.7
-13558.9
-9915

cash-flows.row.account-receivables

-4098.27-3007.3-3643.52576.9
21988
-2136.7
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-1591.37-4830.5-65.94214.3
-4167.4
-5631.5
470.9
-3935.6
-724.8
1854.8
-1021.9
1630
-2111.9
-1951.5
-991.1
-3143.8
-2712
-1485.1

cash-flows.row.account-payables

991.1410702044.6-2271.8
-765.9
1204.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

1273.97730.2-3848.51155.2
-6199.6
3202.2
6278.1
2499.9
-1747.7
-5934.6
-3429
-6241.3
10847.9
-10871.3
-4382.9
-10528.9
-10846.9
-8429.9

cash-flows.row.other-non-cash-items

3543.511819.4-1226.4-2218.3
-3975.6
17591.6
2416.8
-692.7
-403.2
14417.4
2151.9
4158.3
4538.6
5061.3
145
5
1481.3
2464.8

cash-flows.row.net-cash-provided-by-operating-activities

-6672.53000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-2505.74-2990.7-1948-374.7
-2438
-14150.1
-11093.6
-22215
-9464.3
-3843.6
-2877.1
-4725.9
-3659.2
-3230.5
-5020.9
-5693.3
-4464
-5641.7

cash-flows.row.acquisitions-net

-62.5435.7435.55210.4
-76.1
880.3
164.7
-139.1
1128.9
1239.7
1662.4
14.5
1054.4
-585
-240.1
-46
-180
-1367.5

cash-flows.row.purchases-of-investments

-6493.03-7052.3-6951.3-7997.4
-9625.6
-15018.8
-11714.6
-7528.9
-13123.6
-21885.3
-8943.6
-11886.9
-12737.5
-8661.5
-5597.5
-8619.7
-732.3
-5570.3

cash-flows.row.sales-maturities-of-investments

7601.8211357.64411.412237.6
12449.8
10502.3
9573.5
4903.7
16850.2
23432.7
9869.6
11186.7
11714.8
12558
1010
5274.2
1755
5294.5

cash-flows.row.other-investing-activites

868.33472.3-879.90
-971.4
-1182.6
-3066.4
-2670.3
-106.7
261.7
-13.6
-81.3
432.5
1290.6
780.9
-1983.4
-1417.9
-217.6

cash-flows.row.net-cash-used-for-investing-activites

-591.171822.7-4932.39075.9
-661.3
-18968.8
-16136.2
-27649.6
-4715.5
-794.8
-302.4
-5492.8
-3195
1371.5
-9067.7
-11068.3
-5039.1
-7502.6

cash-flows.row.debt-repayment

-20594.98-8199.4-24842.7-17391.7
-19400.6
-11998.1
-5787.6
-7114.1
-17804.1
-4345.8
-26472.7
-7421
-11224.9
-55530.9
-15890.4
-13279.9
-9043.8
-7250

cash-flows.row.common-stock-issued

0000
29919
0
12147
10634.7
2245
8550.8
297.9
0
2000
7250.4
1290.4
5381.7
15227.6
1811.8

cash-flows.row.common-stock-repurchased

-1337.38-674.90-123
0
-48.2
-40.1
-37.3
-15
-7.1
-5
0
-7.3
-7.6
-3.1
-188.4
-1796.9
0

cash-flows.row.dividends-paid

0000
0
0
-2389.9
-1154.3
-323.6
-312.8
-270
0
-472.4
-416.7
-400.2
-484
-9760
0

cash-flows.row.other-financing-activites

28702.1915329.222340.19833.9
10794.4
33906
25.2
-3.8
30140
-9
28310.1
11442
9788.2
47835.7
19320
60860
19520
11654.3

cash-flows.row.net-cash-used-provided-by-financing-activities

5481.326454.9-2502.5-7680.8
21312.7
21859.7
3954.6
2325.3
14242.3
3876
1860.2
4020.9
83.5
-869
4316.7
52289.4
14147
6216.1

cash-flows.row.effect-of-forex-changes-on-cash

-15.047.24.99.4
2.1
0
0
1071.7
0
0
0
0
0
0
0
-40251.9
0
0

cash-flows.row.net-change-in-cash

-1782.773104.2-1955.12259.4
3981.1
-50.8
-774.3
-16228.8
15127.9
-2423.3
1521.6
531.6
-330.9
-913.4
-1880.3
-3250.8
7389.2
-827.5

cash-flows.row.cash-at-end-of-period

24983.217961.84857.66812.7
4553.2
572.1
622.9
1397.2
17626.1
2498.1
4921.4
3399.8
2868.2
3199.1
2575.9
4456.3
7707.1
317.9

cash-flows.row.cash-at-beginning-of-period

26765.994857.66812.74553.2
572.1
622.9
1397.2
17626.1
2498.1
4921.4
3399.8
2868.2
3199.1
4112.5
4456.3
7707.1
317.9
1145.4

cash-flows.row.operating-cash-flow

-6672.53-5180.55474.8855
-16672.5
-2941.6
11407.3
8023.8
5601.1
-5504.6
-36.2
2003.5
2780.7
-1416
2870.6
-4220.1
-1718.7
459.1

cash-flows.row.capital-expenditure

-2505.74-2990.7-1948-374.7
-2438
-14150.1
-11093.6
-22215
-9464.3
-3843.6
-2877.1
-4725.9
-3659.2
-3230.5
-5020.9
-5693.3
-4464
-5641.7

cash-flows.row.free-cash-flow

-9178.27-8171.23526.8480.3
-19110.4
-17091.7
313.7
-14191.2
-3863.2
-9348.2
-2913.4
-2722.4
-878.5
-4646.5
-2150.3
-9913.4
-6182.7
-5182.6

Income Statement Row

MYUNGMOON Pharm co.,Ltd's revenue saw a change of 0.115% compared with the previous period. The gross profit of 017180.KS is reported to be 94515.57. The company's operating expenses are 93551.81, showing a change of 30.537% from the last year. The expenses for depreciation and amortization are 3562.69, which is a -0.175% change from the last accounting period. Operating expenses are reported to be 93551.81, which shows a 30.537% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -0.850% year-over-year growth. The operating income is 963.77, which shows a -0.850% change when compared to the previous year. The change in the net income is -1.575%. The net income for the last year was -4524.84.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

173795.74169567.4152134.9137759.9
127852.9
149346.3
147498.5
140137.9
142179.7
125100.9
105420.7
103723.5
100539
125619.9
105183.3
97191.2
77390.4
60927.9

income-statement-row.row.cost-of-revenue

75824.7175051.874034.175422.1
78861.7
80913
73048.4
60933.1
66001.4
62422.1
51254.8
52634.7
53966.8
56756.6
48062.6
43844.4
31753.2
26271.5

income-statement-row.row.gross-profit

97971.0394515.678100.862337.8
48991.1
68433.3
74450.1
79204.8
76178.3
62678.8
54165.9
51088.7
46572.2
68863.3
57120.7
53346.8
45637.2
34656.4

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

4386.96---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

74889---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

52373.44---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-96631.1-1357.922623.620620.3
45930.1
56128.9
1643.4
5022.5
677.5
-6133.3
257.8
1279.3
44.8
37.5
-327.4
-790.6
-1345.7
-594.1

income-statement-row.row.operating-expenses

4012.9793551.871666.968218.6
77955.2
82727.7
69513.2
71731.5
66120.6
65149
50439.8
46983.3
50297
57915.1
47983.2
46580.5
37759.2
24884.3

income-statement-row.row.cost-and-expenses

127794.52168603.6145701.1143640.7
156816.9
163640.6
142561.6
132664.7
132122
127571.2
101694.6
99618.1
104263.7
114671.8
96045.8
90424.9
69512.4
51155.8

income-statement-row.row.interest-income

219.75223.6150.8172.8
200.3
145.8
152.5
225.6
158.6
287.3
215.7
200
160.9
354.2
502.3
382.9
213.1
157.8

income-statement-row.row.interest-expense

5225.45137.53734.63041.6
4141.9
4580.7
3249.9
2360.8
3039.5
3350.6
3907.6
4111.3
4527.6
5410.9
4028.9
3504.9
1279.6
1003.4

income-statement-row.row.selling-and-marketing-expenses

52373.44---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-5520.5-5745.4-3781.7-717.3
1669.5
-4889.6
-3044.3
2633.2
-1870.3
-7982.5
-3039.7
-3008.4
-5768.6
-5113.5
-3640.8
-3595.1
-2031.2
-1155.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-96631.1-1357.922623.620620.3
45930.1
56128.9
1643.4
5022.5
677.5
-6133.3
257.8
1279.3
44.8
37.5
-327.4
-790.6
-1345.7
-594.1

income-statement-row.row.total-operating-expenses

-5520.5-5745.4-3781.7-717.3
1669.5
-4889.6
-3044.3
2633.2
-1870.3
-7982.5
-3039.7
-3008.4
-5768.6
-5113.5
-3640.8
-3595.1
-2031.2
-1155.5

income-statement-row.row.interest-expense

5225.45137.53734.63041.6
4141.9
4580.7
3249.9
2360.8
3039.5
3350.6
3907.6
4111.3
4527.6
5410.9
4028.9
3504.9
1279.6
1003.4

income-statement-row.row.depreciation-and-amortization

49730.93562.74319.85626.1
5873.4
5658.6
1913.7
2021
2002.7
2022
2305.8
2255.2
2252.4
2278.5
3088.9
3423.6
2420.3
1326.1

income-statement-row.row.ebitda-caps

47775.27---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-1955.63963.86433.9-5880.8
-28964
-14294.4
4936.9
7473.3
10057.7
-2470.3
3726.1
4105.4
-3724.8
10762
9137.5
6766.3
7878
9772.1

income-statement-row.row.income-before-tax

-7476.13-4781.62652.2-6598.1
-27294.5
-19184
1892.6
10106.5
8187.5
-10452.7
686.4
1097
-9493.4
5834.6
5496.7
3171.2
5846.8
8616.6

income-statement-row.row.income-tax-expense

-808.6792.6-5323.8206.1
458.5
1648.9
1564.8
1975.2
1713.4
7411.4
729.4
895.7
3252.9
1767.5
3165.5
370.3
983.4
2033.4

income-statement-row.row.net-income

-6321.51-4524.87868-6804.3
-27753
-20832.8
988.3
7807.5
6745.9
-16135.5
761.5
1026
-12273.4
4554
3067.9
2941
4863.3
6583.2

Frequently Asked Question

What is MYUNGMOON Pharm co.,Ltd (017180.KS) total assets?

MYUNGMOON Pharm co.,Ltd (017180.KS) total assets is 236548793649.000.

What is enterprise annual revenue?

The annual revenue is 87078464047.000.

What is firm profit margin?

Firm profit margin is 0.564.

What is company free cash flow?

The free cash flow is -273.756.

What is enterprise net profit margin?

The net profit margin is -0.036.

What is firm total revenue?

The total revenue is -0.011.

What is MYUNGMOON Pharm co.,Ltd (017180.KS) net profit (net income)?

The net profit (net income) is -4524837269.000.

What is firm total debt?

The total debt is 90482197787.000.

What is operating expences number?

The operating expences are 93551806357.000.

What is company cash figure?

Enretprise cash is 3626317869.000.